SCM
ETON icon

Stonepine Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Stonepine Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-110,000
Closed -$362K – 40
2024
Q2 		$362K Buy
+110,000
New +$385K 0.33% 23

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonepine Capital Management's ETON Position: Q3 2024 in Review

Stonepine Capital Management sold out of Eton Pharmaceutcials (ETON) in Q3 2024, closing a stake of 110,000 shares — an estimated $362K sold.

Stonepine Capital Management first reported a position in ETON in Q2 2024 and held it in 1 quarter. The position peaked at $362K in Q2 2024. 48 funds tracked by Wall St. Rank hold ETON as of Q3 2024.

  • Stonepine Capital Management reported no remaining Eton Pharmaceutcials position as of Q3 2024 after selling out during the quarter.
  • Stonepine Capital Management sold 110,000 Eton Pharmaceutcials shares in Q3 2024, an estimated $362K.
  • Stonepine Capital Management first reported a position in Eton Pharmaceutcials in Q2 2024 and held it in 1 quarter.
  • Stonepine Capital Management's Eton Pharmaceutcials position peaked at $362K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2024.

Based on Stonepine Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.